Uwe Zeymer Selected Research

Hypotension (Low Blood Pressure)

1/2020	Clinical outcomes after cardiac rehabilitation in elderly patients with and without diabetes mellitus: The EU-CaRE multicenter cohort study.
5/2015	Clinical picture and risk prediction of short-term mortality in cardiogenic shock.
6/2012	A randomized, double-blind, active-controlled phase 2 trial to evaluate a novel selective and reversible intravenous and oral P2Y12 inhibitor elinogrel versus clopidogrel in patients undergoing nonurgent percutaneous coronary intervention: the INNOVATE-PCI trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Uwe Zeymer Research Topics

Disease

119	Myocardial Infarction 05/2024 - 02/2002
102	ST Elevation Myocardial Infarction 04/2023 - 04/2003
78	Hemorrhage 01/2024 - 04/2003
67	Cardiogenic Shock 05/2024 - 07/2003
60	Acute Coronary Syndrome 01/2023 - 03/2003
36	Thrombosis (Thrombus) 12/2023 - 03/2004
34	Stroke (Strokes) 01/2024 - 09/2004
33	Shock 05/2024 - 07/2003
31	Infarction (Infarctions) 05/2024 - 02/2002
23	Coronary Artery Disease (Coronary Atherosclerosis) 01/2024 - 05/2007
20	Atrial Fibrillation 01/2024 - 04/2013
14	Heart Failure 04/2024 - 03/2003
13	Hypertension (High Blood Pressure) 12/2016 - 02/2006
12	Non-ST Elevated Myocardial Infarction 04/2023 - 07/2006
12	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 10/2004
8	Diabetes Mellitus 01/2020 - 11/2006
8	Pathologic Constriction (Stenosis) 02/2015 - 03/2004
7	Renal Insufficiency (Renal Failure) 01/2023 - 03/2004
6	Heart Arrest (Cardiac Arrest) 12/2023 - 06/2012
5	Peripheral Arterial Disease 12/2022 - 09/2013
5	Ischemia 01/2018 - 06/2004
5	Unstable Angina 05/2011 - 03/2003
4	Atherosclerosis 01/2024 - 11/2013
4	Ischemic Stroke 12/2023 - 10/2012
4	Embolism (Embolus) 08/2022 - 10/2017
4	Coronary Disease (Coronary Heart Disease) 12/2020 - 12/2006
4	Type 2 Diabetes Mellitus (MODY) 10/2016 - 10/2004
4	Stable Angina 09/2012 - 07/2009
3	Sepsis (Septicemia) 01/2024 - 03/2011
3	Hypotension (Low Blood Pressure) 01/2020 - 06/2012
3	Chronic Obstructive Pulmonary Disease (COPD) 01/2019 - 10/2010
3	Aortic Valve Stenosis (Aortic Stenosis) 12/2017 - 01/2011
3	Glucose Intolerance 08/2013 - 10/2004
2	Ventricular Fibrillation 01/2024 - 01/2020
2	Out-of-Hospital Cardiac Arrest 01/2024 - 12/2021

Drug/Important Bio-Agent (IBA)

29	Glycoproteins (Glycoprotein)IBA 01/2020 - 04/2003
26	Clopidogrel (Plavix)FDA Link 09/2021 - 11/2006
22	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2024 - 11/2006
22	TicagrelorIBA 01/2023 - 09/2014
21	Heparin (Liquaemin)FDA LinkGeneric 10/2017 - 07/2006
14	Platelet Membrane Glycoprotein IIbIBA 04/2019 - 01/2009
13	Prasugrel Hydrochloride FDA Link 09/2021 - 06/2013
13	Enoxaparin (Lovenox)FDA LinkGeneric 08/2017 - 06/2004
12	bivalirudin (Angiomax)FDA Link 10/2017 - 12/2013
9	AnticoagulantsIBA 01/2023 - 12/2009
8	Eptifibatide (Integrilin)FDA Link 04/2013 - 02/2002
7	RivaroxabanIBA 01/2024 - 07/2018
7	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2019 - 08/2006
6	omega-Chloroacetophenone (Mace)IBA 01/2024 - 11/2009
6	Biomarkers (Surrogate Marker)IBA 01/2024 - 07/2012
6	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2023 - 11/2006
6	Purinergic P2Y Receptor AntagonistsIBA 09/2021 - 12/2009
6	Glucose (Dextrose)FDA LinkGeneric 01/2019 - 10/2004
5	Lactic Acid (Lactate)FDA LinkGeneric 01/2021 - 08/2014
5	CreatinineIBA 11/2019 - 07/2015
5	Creatine Kinase (Creatine Phosphokinase)IBA 12/2017 - 02/2009
5	Abciximab (ReoPro)FDA Link 10/2013 - 07/2003
4	sacubitril and valsartan sodium hydrate drug combinationIBA 04/2024 - 01/2020
4	Dabigatran FDA Link 12/2021 - 10/2017
4	Warfarin (Coumadin)FDA LinkGeneric 12/2021 - 10/2017
4	Tenecteplase FDA Link 06/2012 - 04/2003
3	TroponinIBA 12/2021 - 09/2012
3	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2021 - 01/2010
3	oxidized low density lipoproteinIBA 01/2020 - 01/2019
3	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 10/2017 - 12/2009
3	AntithrombinsIBA 12/2016 - 01/2007
3	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 12/2013 - 07/2006
2	Angiotensin Receptors (Angiotensin II Receptor)IBA 04/2024 - 01/2020
2	Neprilysin (Neutral Endopeptidase)IBA 04/2024 - 01/2020
2	Hemoglobins (Hemoglobin)IBA 12/2023 - 01/2019
2	cangrelorIBA 01/2023 - 01/2019
2	APTIBA 08/2022 - 09/2020
2	Vitamin K FDA Link 01/2022 - 07/2018
2	N(4)-oleylcytosine arabinosideIBA 01/2022 - 07/2018
2	N- acetyl- S- (alpha- methyl- 4- (2- methylpropyl)benzeneacetyl)cysteine 4-(nitrooxy)butyl esterIBA 12/2021 - 10/2017

Therapy/Procedure

127	Percutaneous Coronary Intervention 05/2024 - 07/2003
98	Therapeutics 01/2024 - 04/2003
30	Stents 12/2023 - 03/2004
19	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 10/2021 - 09/2003
13	Secondary Prevention 01/2024 - 08/2006
8	Extracorporeal Membrane Oxygenation 05/2024 - 01/2020
8	Renal Replacement Therapy (Therapies, Renal Replacement) 12/2023 - 02/2016
8	Counterpulsation (External Counterpulsation) 06/2020 - 06/2012
7	Resuscitation 05/2024 - 01/2009
7	Contraindications 01/2024 - 11/2013
7	Cardiac Rehabilitation 01/2023 - 01/2019
7	Drug-Eluting Stents 01/2017 - 09/2008
5	Cardiopulmonary Resuscitation (CPR) 01/2024 - 10/2009
5	Thrombectomy 10/2020 - 04/2013
5	Transcatheter Aortic Valve Replacement 12/2017 - 03/2010
5	Thrombolytic Therapy 12/2009 - 10/2003
4	Length of Stay 12/2023 - 09/2004
4	Patient Readmission 01/2023 - 03/2009
4	Time-to-Treatment 01/2014 - 01/2010
3	Drug Therapy (Chemotherapy) 01/2023 - 10/2010
3	Critical Care (Surgical Intensive Care) 12/2021 - 01/2019
3	Artificial Respiration (Mechanical Ventilation) 03/2020 - 03/2011
3	Denervation 12/2016 - 08/2013
3	Catheters 11/2013 - 11/2004
3	Carotid Endarterectomy 07/2009 - 09/2004